亚宝药业集团股份有限公司 关于控股股东部分股份解除质押的公告

Core Points - The announcement details the release of share pledges by the controlling shareholder of Yabao Pharmaceutical Group Co., Ltd. [1] - As of the announcement date, the controlling shareholder, Shanxi Yabao Investment Group Co., Ltd., holds 94,300,000 shares, representing 13.47% of the total share capital [2] - After the release of the pledge, the total number of pledged shares held by Yabao Investment is 27,150,000, which accounts for 28.79% of its total shares and 3.88% of the company's total share capital [2] Summary of Share Pledge Release - The company received a notice on April 18, 2025, regarding the release of a pledge for 4,000,000 unrestricted circulating shares to Shanxi Securities Co., Ltd. [1] - The company will fulfill its disclosure obligations in accordance with relevant laws and regulations if there are any subsequent pledge plans by Yabao Investment [1]